Bendamustine Hydrocloride 25mg (equivalent to Bendamustine 22.7mg) - search results

Singapore - English - HSA (Health Sciences Authority)

symbenda 25 mg powder for solution for injection

eisai (singapore) pte. ltd. - bendamustine hydrocloride 25mg (equivalent to bendamustine 22.7mg) - injection, powder, lyophilized, for solution - 25 mg - bendamustine hydrocloride 25mg (equivalent to bendamustine 22.7mg) 25 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

bendamustine 25 mg/ml concentrate for solution for infusion

accord healthcare ireland ltd. - bendamustine hydrochloride - concentrate for solution for infusion - bendamustine

Singapore - English - HSA (Health Sciences Authority)

symbenda 100mg powder for solution for injection

eisai (singapore) pte. ltd. - bendamustine hydrocloride 100mg (equivalent to bendamustine 90.8 mg) - injection, powder, lyophilized, for solution - 100mg - bendamustine hydrocloride 100mg (equivalent to bendamustine 90.8 mg) 100mg

Australia - English - Department of Health (Therapeutic Goods Administration)

bendamustine juno bendamustine hydrochloride 100 mg powder for injection vial

juno pharmaceuticals pty ltd - bendamustine hydrochloride, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c). efficacy relative to first-line therapies other than chlorambucil has not been established.,previously untreated indolent cd20-positive, stage iii-iv non-hodgkin?s lymphoma, in combination with rituximab.,previously untreated cd20-positive, stage iii-iv mantle cell lymphoma in combination with rituximab, in patient?s ineligible for autologous stem cell transplantation.,relapsed/refractory indolent non-hodgkin?s lymphoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

bendamustine juno bendamustine hydrochloride 25 mg powder for injection vial

juno pharmaceuticals pty ltd - bendamustine hydrochloride, quantity: 25 mg - injection, powder for - excipient ingredients: mannitol - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c). efficacy relative to first-line therapies other than chlorambucil has not been established.,previously untreated indolent cd20-positive, stage iii-iv non-hodgkin?s lymphoma, in combination with rituximab.,previously untreated cd20-positive, stage iii-iv mantle cell lymphoma in combination with rituximab, in patient?s ineligible for autologous stem cell transplantation.,relapsed/refractory indolent non-hodgkin?s lymphoma.